MedPath

The Promotion Effect of Probiotics on Weight Loss in Overweight People

Not Applicable
Recruiting
Conditions
Overweight or Obesity
Registration Number
NCT06653101
Lead Sponsor
Wecare Probiotics Co., Ltd.
Brief Summary

To assess the effectiveness and safety of the use of probiotics as a food supplement compared to placebo in promoting weight loss in overweight subjects.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
70
Inclusion Criteria
  1. 18-65 years old;
  2. BMI ≥ 24 kg/m2 or men with a body fat percentage of ≥ 25% and women with a body fat percentage of ≥ 30%;
  3. Normal liver function indexes;
  4. Willing to complete study-related questionnaires and diaries and complete all clinical visits.
Read More
Exclusion Criteria
  1. Those who have been diagnosed with high uric acid or gout are not recommended to participate in the test;
  2. Psychiatric or neurological diseases, celiac disease, lactose intolerance, allergies;
  3. Have the following diseases: irritable bowel syndrome, ulcerative colitis, fatty liver, liver cirrhosis, etc.;
  4. Recently treated with antibiotics (i.e., < 3 months prior to the start of the study);
  5. Participants who smoked more than 10 cigarettes per day were excluded;
  6. It is not recommended to participate in other special circumstances, such as those who are allergic to probiotic products;
  7. Pregnant and lactating women are not suitable for experiments.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Body Mass Index (BMI)week 0, week 4, week 8 and week 12

BMI = Weight (kg) / \[Height (m)\]². 24kg/m² ≤ BMI \< 28 kg/m² is in the overweight range, and BMI ≥ 28 kg/m² is in the obesity range.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fei Xu

🇨🇳

Zhengzhou, None Selected, China

© Copyright 2025. All Rights Reserved by MedPath